Similar articles

• Supersensitivity of cerebral dopamine receptors during on-going chronic (six months) administration of trifluoperazine to rats [proceedings].

  Clow A, Jenner P, Marsden CD. Clow A, et al. Br J Pharmacol. 1978 Nov;64(3):414P. Br J Pharmacol. 1978. PMID: 719266 Free PMC article. No abstract available.
• Changes in cerebral dopamine function induced by a year's administration of trifluoperazine or thioridazine and their subsequent withdrawal.

  Clow A, Theodorou A, Jenner P, Marsden CD. Clow A, et al. Adv Biochem Psychopharmacol. 1980;24:335-40. Adv Biochem Psychopharmacol. 1980. PMID: 7190762 No abstract available.
• Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brain.

  Theodorou A, Gommeren W, Clow A, Leysen J, Jenner P, Marsden CD. Theodorou A, et al. Life Sci. 1981 Apr 6;28(14):1621-7. doi: 10.1016/0024-3205(81)90317-9. Life Sci. 1981. PMID: 7242249 No abstract available.
• Location of receptors mediating hypothermia after injection of dopamine agonists in rats [proceedings].

  Cox B, Lee TF. Cox B, et al. Br J Pharmacol. 1977 Mar;59(3):467P-468P. Br J Pharmacol. 1977. PMID: 843709 Free PMC article. No abstract available.
• The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles.

  Breese GR, Knapp DJ, Criswell HE, Moy SS, Papadeas ST, Blake BL. Breese GR, et al. Brain Res Brain Res Rev. 2005 Feb;48(1):57-73. doi: 10.1016/j.brainresrev.2004.08.004. Brain Res Brain Res Rev. 2005. PMID: 15708628 Review.